Entrada Therapeutics (TRDA) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
Entrada Therapeutics (TRDA) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Entrada Therapeutics | 300.62 Mn | 300.62 Mn | - | 38.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.94 Mn |
| Mar 31, 2026 | 38.82 Mn |
| Dec 31, 2025 | 38.28 Mn |
| Sep 30, 2025 | 38.22 Mn |
| Jun 30, 2025 | 38.03 Mn |
| Mar 31, 2025 | 37.94 Mn |
| Dec 31, 2024 | 37.57 Mn |
| Sep 30, 2024 | 37.40 Mn |
| Jun 30, 2024 | 37.17 Mn |
| Mar 31, 2024 | 33.60 Mn |
| Dec 31, 2023 | 33.44 Mn |
| Sep 30, 2023 | 33.34 Mn |
| Jun 30, 2023 | 33.21 Mn |
| Mar 31, 2023 | 33.13 Mn |
| Dec 31, 2022 | 31.39 Mn |
| Sep 30, 2022 | 31.33 Mn |
| Jun 30, 2022 | 31.28 Mn |
| Mar 31, 2022 | 31.26 Mn |
| Dec 31, 2021 | 6.27 Mn |
| Sep 30, 2021 | 1.48 Mn |